Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?
As an appealing alternative to treat and prevent diseases ranging from cancer to COVID-19, mRNA has demonstrated significant clinical effects. Nanotechnology facilitates the successful implementation of the systemic delivery of mRNA for safe human consumption. In this manuscript, we provide an overv...
Main Authors: | Matteo Puccetti, Aurelie Schoubben, Stefano Giovagnoli, Maurizio Ricci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/3/2218 |
Similar Items
-
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation
by: Matteo Puccetti, et al.
Published: (2022-03-01) -
Ionizable Lipid Nanoparticles for mRNA Delivery
by: Xuefeng Tang, et al.
Published: (2023-08-01) -
Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
by: Hong-Li Wang, et al.
Published: (2022-08-01) -
Biologics, theranostics, and personalized medicine in drug delivery systems
by: Matteo Puccetti, et al.
Published: (2024-03-01) -
A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery
by: Gonna Somu Naidu, et al.
Published: (2023-07-01)